Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Biomarkers for Insulin Resistance and Inflammation and the Risk for All-Cause Dementia and Alzheimer Disease: Results From the Framingham Heart Study.
van Himbergen TM, Beiser AS, Ai M, Seshadri S, Otokozawa S, Au R, Thongtang N, Wolf PA, Schaefer EJ.
Arch Neurol. 2012 Jan 2. [Epub ahead of print]
Related citations
Proteomic changes in cerebrospinal fluid of presymptomatic and affected persons carrying familial Alzheimer disease mutations.
Ringman JM, Schulman H, Becker C, Jones T, Bai Y, Immermann F, Cole G, Sokolow S, Gylys K, Geschwind DH, Cummings JL, Wan HI.
Arch Neurol. 2012 Jan;69(1):96-104.
A comprehensive genetic association study of Alzheimer disease in African Americans.
Logue MW, Schu M, Vardarajan BN, Buros J, Green RC, Go RC, Griffith P, Obisesan TO, Shatz R, Borenstein A, Cupples LA, Lunetta KL, Fallin MD, Baldwin CT, Farrer LA; Multi-Institutional Research on Alzheimer Genetic Epidemiology (MIRAGE) Study Group.
Arch Neurol. 2011 Dec;68(12):1569-79.
Positron emission tomography and neuropathologic estimates of fibrillar amyloid-β in a patient with Down syndrome and Alzheimer disease.
Sabbagh MN, Fleisher A, Chen K, Rogers J, Berk C, Reiman E, Pontecorvo M, Mintun M, Skovronsky D, Jacobson SA, Sue LI, Liebsack C, Charney AS, Cole L, Belden C, Beach TG.
Arch Neurol. 2011 Nov;68(11):1461-6.
Clusterin as an Alzheimer biomarker.
Hardy J, Guerreiro R, Lovestone S.
Arch Neurol. 2011 Nov;68(11):1459-60. No abstract available.
Cholesterol level and statin use in Alzheimer disease: II. Review of human trials and recommendations.
Shepardson NE, Shankar GM, Selkoe DJ.
Arch Neurol. 2011 Nov;68(11):1385-92. Review.
Amyloid imaging: liberal or conservative? Let the data decide.
Jagust WJ.
Arch Neurol. 2011 Nov;68(11):1377-8. Epub 2011 Jul 11. No abstract available.
Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab.
Ostrowitzki S, Deptula D, Thurfjell L, Barkhof F, Bohrmann B, Brooks DJ, Klunk WE, Ashford E, Yoo K, Xu ZX, Loetscher H, Santarelli L.
Arch Neurol. 2012 Feb;69(2):198-207. Epub 2011 Oct 10.
Role of family history for Alzheimer biomarker abnormalities in the adult children study.
Xiong C, Roe CM, Buckles V, Fagan A, Holtzman D, Balota D, Duchek J, Storandt M, Mintun M, Grant E, Snyder AZ, Head D, Benzinger TL, Mettenburg J, Csernansky J, Morris JC.
Arch Neurol. 2011 Oct;68(10):1313-9.
Cholesterol level and statin use in Alzheimer disease: I. Review of epidemiological and preclinical studies.
Arch Neurol. 2011 Oct;68(10):1239-44. Review.
Longitudinal change of biomarkers in cognitive decline.
Lo RY, Hubbard AE, Shaw LM, Trojanowski JQ, Petersen RC, Aisen PS, Weiner MW, Jagust WJ; Alzheimer's Disease Neuroimaging Initiative.
Arch Neurol. 2011 Oct;68(10):1257-66. Epub 2011 Jun 13.
Autosomal recessive causes likely in early-onset Alzheimer disease.
Wingo TS, Lah JJ, Levey AI, Cutler DJ.
Arch Neurol. 2012 Jan;69(1):59-64. Epub 2011 Sep 12.
Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial.
Craft S, Baker LD, Montine TJ, Minoshima S, Watson GS, Claxton A, Arbuckle M, Callaghan M, Tsai E, Plymate SR, Green PS, Leverenz J, Cross D, Gerton B.
Arch Neurol. 2012 Jan;69(1):29-38. Epub 2011 Sep 12.
Alois Alzheimer's case, Auguste D., did not carry the N141I mutation in PSEN2 characteristic of Alzheimer disease in Volga Germans.
Müller U, Winter P, Graeber MB.
Arch Neurol. 2011 Sep;68(9):1210-1, author reply 1211. No abstract available.
Rapidly progressive Alzheimer disease.
Schmidt C, Wolff M, Weitz M, Bartlau T, Korth C, Zerr I.
Arch Neurol. 2011 Sep;68(9):1124-30. Review.
Cerebrospinal fluid biomarkers, education, brain volume, and future cognition.
Roe CM, Fagan AM, Grant EA, Marcus DS, Benzinger TL, Mintun MA, Holtzman DM, Morris JC.
Arch Neurol. 2011 Sep;68(9):1145-51.
Evidence for ordering of Alzheimer disease biomarkers.
Jack CR Jr, Vemuri P, Wiste HJ, Weigand SD, Aisen PS, Trojanowski JQ, Shaw LM, Bernstein MA, Petersen RC, Weiner MW, Knopman DS; Alzheimer's Disease Neuroimaging Initiative.
Arch Neurol. 2011 Dec;68(12):1526-35. Epub 2011 Aug 8.
The dynamics of cortical and hippocampal atrophy in Alzheimer disease.
Sabuncu MR, Desikan RS, Sepulcre J, Yeo BT, Liu H, Schmansky NJ, Reuter M, Weiner MW, Buckner RL, Sperling RA, Fischl B; Alzheimer's Disease Neuroimaging Initiative.
Arch Neurol. 2011 Aug;68(8):1040-8.
Association and expression analyses with single-nucleotide polymorphisms in TOMM40 in Alzheimer disease.
Cruchaga C, Nowotny P, Kauwe JS, Ridge PG, Mayo K, Bertelsen S, Hinrichs A, Fagan AM, Holtzman DM, Morris JC, Goate AM; Alzheimer's Disease Neuroimaging Initiative.
Arch Neurol. 2011 Aug;68(8):1013-9.
Ecology of the aging human brain.
Sonnen JA, Santa Cruz K, Hemmy LS, Woltjer R, Leverenz JB, Montine KS, Jack CR, Kaye J, Lim K, Larson EB, White L, Montine TJ.
Arch Neurol. 2011 Aug;68(8):1049-56.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on